Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H J Malling

Showing results (121-130 of 126) with videos related to

Pageof 13
Sort By:
You have reached the last page of results.This site can display upto 126 results.
Allergy|April 26, 2014
Recommendations for the standardization of clinical outcomes used in allergen immunotherapy trials for allergic rhinoconjunctivitis: an EAACI Position PaperO Pfaar, P Demoly, R Gerth van Wijk, et al.
Allergy|January 31, 2018
EAACI guidelines on allergen immunotherapy: Executive statementA Muraro, G Roberts, S Halken, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|December 22, 1998
Allergen immunotherapy: therapeutic vaccines for allergic diseases. World Health Organization. American academy of Allergy, Asthma and ImmunologyJ Bousquet, R Lockey, H J Malling, et al.
Allergy|October 29, 2009
The CONSORT statement checklist in allergen-specific immunotherapy: a GA2LEN paperP J Bousquet, J Brozek, C Bachert, et al.
Allergy|April 19, 2011
How to design and evaluate randomized controlled trials in immunotherapy for allergic rhinitis: an ARIA-GA(2) LEN statementJean Bousquet, H J Schünemann, P J Bousquet, et al.
Clinical and Translational Allergy|November 30, 2016
Allergy immunotherapy across the life cycle to promote active and healthy ageing: from research to policies: An AIRWAYS Integrated Care Pathways (ICPs) programme item (Action Plan B3 of the European Innovation Partnership on active and healthy ageing) and the Global Alliance against Chronic Respiratory Diseases (GARD), a World Health Organization GARD research demonstration projectM A Calderon, P Demoly, T Casale, et al.
Pageof 13

Showing results (121-130 of 126) with videos related to

Sort By:
Pageof 13
You have reached the last page of results.This site can display upto 126 results.
Allergy|April 26, 2014
Recommendations for the standardization of clinical outcomes used in allergen immunotherapy trials for allergic rhinoconjunctivitis: an EAACI Position PaperO Pfaar, P Demoly, R Gerth van Wijk, et al.
Allergy|January 31, 2018
EAACI guidelines on allergen immunotherapy: Executive statementA Muraro, G Roberts, S Halken, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|December 22, 1998
Allergen immunotherapy: therapeutic vaccines for allergic diseases. World Health Organization. American academy of Allergy, Asthma and ImmunologyJ Bousquet, R Lockey, H J Malling, et al.
Allergy|October 29, 2009
The CONSORT statement checklist in allergen-specific immunotherapy: a GA2LEN paperP J Bousquet, J Brozek, C Bachert, et al.
Allergy|April 19, 2011
How to design and evaluate randomized controlled trials in immunotherapy for allergic rhinitis: an ARIA-GA(2) LEN statementJean Bousquet, H J Schünemann, P J Bousquet, et al.
Clinical and Translational Allergy|November 30, 2016
Allergy immunotherapy across the life cycle to promote active and healthy ageing: from research to policies: An AIRWAYS Integrated Care Pathways (ICPs) programme item (Action Plan B3 of the European Innovation Partnership on active and healthy ageing) and the Global Alliance against Chronic Respiratory Diseases (GARD), a World Health Organization GARD research demonstration projectM A Calderon, P Demoly, T Casale, et al.
Pageof 13